NASDAQ:KEQU - Nasdaq - US4928541048 - Common Stock - Currency: USD
56.67
+1.87 (+3.41%)
The current stock price of KEQU is 56.67 USD. In the past month the price increased by 46.55%. In the past year, price increased by 20.06%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.11 | 233.80B | ||
ISRG | INTUITIVE SURGICAL INC | 69.86 | 191.29B | ||
BSX | BOSTON SCIENTIFIC CORP | 39.46 | 157.61B | ||
SYK | STRYKER CORP | 31.41 | 150.40B | ||
MDT | MEDTRONIC PLC | 15.64 | 110.32B | ||
BDX | BECTON DICKINSON AND CO | 12.13 | 48.97B | ||
EW | EDWARDS LIFESCIENCES CORP | 30.08 | 45.88B | ||
IDXX | IDEXX LABORATORIES INC | 46.61 | 43.06B | ||
RMD | RESMED INC | 28.1 | 37.41B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 16.17 | 34.06B | ||
DXCM | DEXCOM INC | 52.32 | 33.85B | ||
STE | STERIS PLC | 25.57 | 23.46B |
Kewaunee Scientific Corp. engages in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The company is headquartered in Statesville, North Carolina and currently employs 1,006 full-time employees. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The firm's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. The company has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.
KEWAUNEE SCIENTIFIC CP
2700 W Front St
Statesville NORTH CAROLINA 28677 US
CEO: Thomas D. Hull
Employees: 1006
Phone: 17048737202
The current stock price of KEQU is 56.67 USD. The price increased by 3.41% in the last trading session.
The exchange symbol of KEWAUNEE SCIENTIFIC CP is KEQU and it is listed on the Nasdaq exchange.
KEQU stock is listed on the Nasdaq exchange.
KEWAUNEE SCIENTIFIC CP (KEQU) has a market capitalization of 161.51M USD. This makes KEQU a Micro Cap stock.
KEWAUNEE SCIENTIFIC CP (KEQU) currently has 1006 employees.
KEWAUNEE SCIENTIFIC CP (KEQU) has a support level at 37.28. Check the full technical report for a detailed analysis of KEQU support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
KEQU does not pay a dividend.
KEWAUNEE SCIENTIFIC CP (KEQU) will report earnings on 2025-09-09.
The PE ratio for KEWAUNEE SCIENTIFIC CP (KEQU) is 66.67. This is based on the reported non-GAAP earnings per share of 0.85 and the current share price of 56.67 USD. Check the full fundamental report for a full analysis of the valuation metrics for KEQU.
The outstanding short interest for KEWAUNEE SCIENTIFIC CP (KEQU) is 2.25% of its float. Check the ownership tab for more information on the KEQU short interest.
ChartMill assigns a technical rating of 7 / 10 to KEQU. When comparing the yearly performance of all stocks, KEQU is one of the better performing stocks in the market, outperforming 88.59% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to KEQU. KEQU has only an average score on both its financial health and profitability.
Over the last trailing twelve months KEQU reported a non-GAAP Earnings per Share(EPS) of 0.85. The EPS decreased by -71.96% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 7.99% | ||
ROA | 9.29% | ||
ROE | 28.92% | ||
Debt/Equity | 1.04 |
ChartMill assigns a Buy % Consensus number of 83% to KEQU. The Buy consensus is the average rating of analysts ratings from 7 analysts.